Innovative approach for prevention and treatment of post subarachnoid hemorrhage vasospasm: A preliminary report Neelam K Venkataraman, Shailesh A.V.Rao, Arun L. Naik, Kishore Shetty, Paparaja Murthy, Abhilash Bansal, Christos Panotopoulos Asian Journal o
Outcome of microvascular decompression for trigeminal neuralgia using autologous muscle graft: A five year prospective study Palaniappan Manickam Jagannath, Neelam Krishnan Venkataramana, Abhilash Bansal, Madineni Ravichandra Asian Journal of Neurosurgery
Open-labeled study of Unilateral Autologous Bone-Marrow-Derived mesenchymal Stem Cell Transplantation in Parkinson’s Disease Neelam K. Venkataramana, Satish K.V. Kumar, Sudheer Balaraju, Radhika Chemmangattu Radhakrishnan, Abhilash Bansal, Ashish Dixit, D
Ex Vivo-Expanded Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in Human Spinal Cord Injury/Paraplegia: a Pilot Clinical study Rakhi Pal; Neelam K. Venkataramana; Majahar Jaan as Majahar Jan; Abhilash Bansal; Sudheer Balaraju; Majahar Jaan; Ravi
White cerebellum Sign – A case report and review of Literature Dwarakanath S, Bansal A, Rudrappa S, Gopal S, Venkataramana NK Journal of Pediatric Neurosciences 2006, January, Volume 1, Issue 3, pp. 22
Participated Actively and well Versed with Stem Cell Therapy of Degenerative and Traumatic Neurological Conditions.
Participated in “An assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy. International Multicentre study” as coordinator during November 2008 – May 2009.
Participated in “Clinical Safety/Tolerability of HF 0220 and its effect on Biochemical Markers Relevant to Patients with a Diagnosis of Mild to Moderate Alzheimer’s Disease” as co-investigator in October 2007.
Participated in “Trial F7CBI” conducted in Head Injury Patients from 2005 to 2006 as study coordinator. This multicentric, prospective, double blind study was conducted by Novo Nordisk and evaluated the effect of recombinant Factor VIIa in Trauma patients
Participated in “Efficacy and safety of AP 12009 in Adult Patients wiuth Recurrent or Refractory Anaplastic Aastrocytoma (WHO grade III) as Compared to Standard Treatment with Temozolomide or BCNU: A Randomized, Actively controlled, Open Label Clinical Ph